A carregar...
Chronic Cholestatic Liver Injury Attributable to Vedolizumab
Drug-induced liver injury is a rare but clinically important diagnosis. Vedolizumab is an α4β7 integrin inhibitor recently approved for use in patients with moderate-to-severe inflammatory bowel disease. Cases of hepatoxicity due to vedolizumab in the pre-marketing stage were rare, and all cases res...
Na minha lista:
| Publicado no: | J Clin Transl Hepatol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
XIA & HE Publishing Inc.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5075012/ https://ncbi.nlm.nih.gov/pubmed/27777897 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2016.00018 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|